Table 1.
Demographic characteristics of participants at entry to the trial
| Methylnaltrexone (N = 41) |
Placebo (N = 43) |
All (N = 84) |
|
|---|---|---|---|
| Gender [N (%)] | |||
| Female | 14 (34.2) | 12 (27.9) | 26 (31) |
| Male | 27 (65.9) | 31 (72.1) | 58 (69) |
| Age [mean (SD)] | 55.6 (14.8) | 58.6 (17.3) | 57.1 (16.1) |
|
BMI (kg/m2) [median (IQR)] | |||
| Females | 25.4 (22, 29.5) | 24.3 (22.7, 34.8) | 25 (22.5, 33.6) |
| Males | 24.5 (23.1, 29.4) | 25.3 (22.7, 27.7) | 24.7 (22.9, 27.8) |
| Ethnicity [N (%)] | |||
| Caucasian | 24 (58.6) | 28 (71.8) | 52 (61.8) |
| Asian | 12 (29.3) | 9 (23.1) | 21 (25) |
| Black | 3 (7.3) | 2 (5.1) | 5 (6) |
| Other white or white background | 1 (2.4) | 0 (0) | 1 (1.2) |
| Other | 1 (2.4) | 4 (10) | 5 (6) |